Monday, September 7, 2026
spot_img

JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija‘ unaudited financial information for nine months of 2025

In the nine months of 2025, the net turnover was 1 444.4 thousand. EUR, which is 21.0% more than in the nine months of the previous year, but the profit before taxes was 95.5 thousand. EUR – by 11.1 thousand EUR more compared to the corresponding period of the previous year.

JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ (hereinafter referred to as the Company) is the only producer of high-quality breeding bull semen and one of the largest suppliers of it in Latvia. The second largest field of the Company’s basic economic activities is the milk testing services. The Company also provides other breeding related services – consultations on issues of cattle breeding, feeding and keeping, evaluation of cow exterior, artificial insemination of cows, initial processing of the supervisory data. The company offers Latvian farms the opportunity to test herd animal genome samples in US and European genetic laboratories.

Valda Mālniece

Member of the Management Board, 
Manager of the Financial and Accounting department

E-mail: [email protected]

Attachment

  • Siguldas_CMAS_Financial_information_for_9 months_of_2025

Powered by SlickText.com

Hot this week

Pharma Equity Group A/S – Challenge to Arbitral Award

 07 September 2026 Announcement no. 11 Pharma Equity Group A/S –...

Davidson Kempner Capital Management LP : Form 8.3 – Tate & Lyle plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY...

The Extraordinary General Shareholders’ Meeting of Pieno žvaigždės is convened

The Extraordinary General Shareholders' Meeting of Pieno žvaigždės is...

AS Tallink Grupp Managers’ Transactions – Eve Pant

Person subject to the notification requirementName: Pant, EvePosition: Member...

AS Tallink Grupp Managers’ Transactions – Eve Pant

Person subject to the notification requirementName: Pant, EvePosition: Member...

Topics

Pharma Equity Group A/S – Challenge to Arbitral Award

 07 September 2026 Announcement no. 11 Pharma Equity Group A/S –...

Davidson Kempner Capital Management LP : Form 8.3 – Tate & Lyle plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY...

The Extraordinary General Shareholders’ Meeting of Pieno žvaigždės is convened

The Extraordinary General Shareholders' Meeting of Pieno žvaigždės is...

AS Tallink Grupp Managers’ Transactions – Eve Pant

Person subject to the notification requirementName: Pant, EvePosition: Member...

AS Tallink Grupp Managers’ Transactions – Eve Pant

Person subject to the notification requirementName: Pant, EvePosition: Member...

AS Tallink Grupp Managers’ Transactions – Enn Pant

Person subject to the notification requirementName: Pant, EnnPosition: Chairman...

AS Tallink Grupp Managers’ Transactions – Enn Pant

Person subject to the notification requirementName: Pant, EnnPosition: Chairman...
spot_img

Related Articles

Popular Categories

spot_img